Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options 
Pivot Bio Evolving World-Class Digital Strategy
Company Appoints Ag Technology Expert Deepak Pillai as Head of Digital MINNEAPOLIS, Sept. 26, 2025 /PRNewswire/ -- Pivot Bio, one...
Octagos Named Among TIME’s World’s Top HealthTech Companies 2025
Exclusive Recognition Highlights Octagos as the First Choice in Remote Cardiac Monitoring HOUSTON, Sept. 26, 2025 /PRNewswire/ -- Octagos, the leader...
NYSE Content Advisory: Pre-Market Update + Wall Street digests August PCE data
NEW YORK, Sept. 26, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from...
Axtria Recognized as Leading AI Service Provider with Minsky Award at Cypher 2025
NEW DELHI, Sept. 26, 2025 /PRNewswire/ -- Axtria Inc., a global leader in AI-first data analytics solutions for the life...
“Mr. Fix-It,” Lou Manfredini, Spotlights Genesis+HOCl as a Breakthrough Against Airborne Mold on HouseSmarts Radio
FREDERICK, Md., Sept. 26, 2025 /PRNewswire/ -- For more than 30 years, Lou Manfredini—better known as Mr. Fix-It—has been America's trusted...
Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care
New Solution Provides an Unprecedented Set of Tools, Empowering Clinical Teams With Choice and Flexibility to Deliver Adaptive Care—Tailoring Radiotherapy...
Deep EigenMatics Receives United States Patent for Inventing Breakthrough Artificial Intelligence Method for Protein Design and Drug Discovery
SUGAR LAND, Texas, Sept. 26, 2025 /PRNewswire/ -- Deep EigenMatics, a startup developing innovative Artificial Intelligence methods for drug discovery and...
Aesthetic Surgery Center Wins First Place in Three Categories in the 2025 Best of Naples Community’s Choice Awards
For the eighth year, the Aesthetic Surgery Center is honored by the Naples Community's Choice Awards, with recognition spanning surgical...
Exousia Pro Reports Positive Outcome in Legal Proceeding
Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia...
CASI Pharmaceuticals Appoints James Huang to Board of Directors
- Industry veteran brings over 35 years of biotech experience as a successful entrepreneur and investor- Operating experience to significantly...
Medical Care Technologies Inc. Introduces AI-Powered Facial Analysis for Diabetic Retinopathy Detection
MESA, ARIZONA / ACCESS Newswire / September 26, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) unveiled its AI Facial...
African Leaders Call for Bold, United Action to Tackle Global Health Crises and Sustain Malaria Progress
NEW YORK CITY, NY / ACCESS Newswire / September 26, 2025 / African Heads of State and Government convened global...
Shape Therapeutics Announces Multiple Oral and Poster Presentations at the European Society of Gene & Cell Therapy 32nd Annual Congress
Talks will cover the use of a novel BBB-penetrant, AAV5-derived CNS capsid and development of an RNA-targeting disease-modifying gene therapy,...
New Clue Survey Reveals Misinformation About Reproductive Health is a Top Concern for American Women
The State of Female Reproductive Health Knowledge in the US 82% of U.S. women are concerned about encountering medical misinformation...
UPDATE — ADvantage Therapeutics Awarded $2.5 Million NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the Clinic
MIAMI, Sept. 26, 2025 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc., a biotechnology company developing novel therapies for neurodegenerative diseases, today...
Shriners Hospitals for Children Canada Hosts Fundraising Gala Celebrating 100 Years of Hope, Healing, and Innovation
MONTREAL, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Shriners Hospitals for Children Canada is proud to celebrate its centennial with an...
SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer
FORT LAUDERDALE, Fla., Sept. 26, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII),...
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.
CINCINNATI, OH, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the “Company”) a commercial stage biotechnology...
Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in...
Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement
CINCINNATI, OH & FORT LEE, NJ, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO), a commercial-stage biotechnology company...